Oncoinvent plans private placement raising up to NOK 140 million at NOK 90 a share

• Oncoinvent retained ABG Sundal Collier, DNB Carnegie for a private placement of new shares raising up to NOK 140 million.
• Offer price fixed at NOK 90 per share; bookbuilding opens today 16:30 CEST, closes Sept. 23 at 08:00 CEST.
• Minimum application set at the NOK equivalent of EUR 100,000; allocation set by the board with full allocation to pre-committed investors.
• Two largest shareholders pre-committed NOK 17.4 million and NOK 17.3 million; CEO, CFO, chair, COO, board member also subscribe.
• Proceeds target phase 2 readout in March/April 2027, full recruitment in H1 2027, regulatory alignment, phase 3 readiness; runway into H2 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncoinvent ASA published the original content used to generate this news brief via Cision (Ref. ID: 20260922:BIT:3886:0) on September 22, 2026, and is solely responsible for the information contained therein.